Sectors
MTNB
Matinas BioPharma Holdings, Inc.
0.26
1 x 0.23
1 x 0.28
bid
ask
-
0.00
1.60%
09:39 AM
timesize
| Ytd | -54.83% | |
| 1y | -83.46% |
0.26
day range
0.27
0.23
52 week range
3.09
| Open | 0.26 | Prev Close | 0.27 | Low | 0.26 | High | 0.27 | Mkt Cap | 1.70M |
| Vol | 65.68K | Avg Vol | 5.31M | EPS | -2.03 | P/E | -0.13 | Forward P/E | -0.17 |
| Beta | 1.76 | Short Ratio | 0.19 | Inst. Own | 26.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 0.54 | 200-d Avg | 0.69 | 1yr Est | 30.00 |
| Income Statement | |||
| Operating Expenses | 1.94M | ||
| Selling, General and Administrative Expense | 1.94M | ||
| Operating Income | -1.94M | ||
| Net Income | -1.92M | ||
| Net Income Common Stock | -1.92M | ||
| Net Income Common Stock (USD) | -1.92M | ||
| Consolidated Income | -1.92M | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -1.92M | ||
| Earning Before Interest & Taxes (USD) | -1.92M | ||
| Weighted Average Shares | 6.41M | ||
| Weighted Average Shares Diluted | 6.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.40M | ||
| Cash and Equivalents (USD) | 2.40M | ||
| Investments | 250.00K | ||
| Investments Current | 50.00K | ||
| Investments Non-Current | 200.00K | ||
| Current Assets | 2.82M | ||
| Property, Plant & Equipment Net | 599.00K | ||
| Total Assets | 5.87M | ||
| Debt Current | 720.00K | ||
| Total Debt | 1.19M | ||
| Current Liabilities | 2.13M | ||
| Debt Non-Current | 469.00K | ||
| Total Liabilities | 2.85M | ||
| Accumulated Retained Earnings (Deficit) | -212.71M | ||
| Shareholders Equity | 3.02M | ||
| Shareholders Equity (USD) | 3.02M | ||
| Assets Non-Current | 3.06M | ||
| Total Debt (USD) | 1.19M | ||
| Liabilities Non-Current | 726.00K | ||
| Trade and Non-Trade Payables | 712.00K | ||
| Tax Liabilities | 257.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 74.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.60M | ||
| Net Cash Flow from Operations | -1.60M | ||
| Share Based Compensation | 113.00K | ||